No Data
Leerink Partners Maintains Progyny(PGNY.US) With Hold Rating, Cuts Target Price to $20
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $21
Progyny's Premarket Value Rises 5.8% on Improved 4Q Forecast
Express News | Progyny Inc : Leerink Partners Raises Target Price to $20 From $17
Progyny Sees Q4 Results Slightly Above Guidance Ranges Provided in November
Express News | Progyny : Now Expect Q4 Revenue, Net Income and Adj Ebitda Slightly Above Ranges Provided in Nov